Validating New Molecular Assays Considerations in Choosing a Platform and Validation Process

Molecular Testing and Applications Molecular profiling Risk assessment Risk management Micro-RNAs Somatic/driver mutations Susceptibility genes Methylation Epigenetic changes Prediction of therapeutic response Prognosis Therapeutic monitoring Patient stratification Alterations in gene expression
Maria E.Arcila MD
Molecular Hematopathology Memorial Sloan Kettering Cancer center
国内会议
上海
英文
1-14
2017-07-28(万方平台首次上网日期,不代表论文的发表时间)